Journal article
The cost-effectiveness of the use of clopidogrel in acute coronary syndromes in five countries based upon the CURE study
Abstract
Background The CURE study demonstrated that clopidogrel prevents a range of ischaemic cardiovascular events in patients with Acute Coronary Syndromes (unstable angina or non-ST-segment elevation MI). Design We undertook an economic analysis of the use of clopidogrel in the UK, USA, Sweden, France and Canada based on the CURE study. Methods The costs of hospitalization, study drug and other medications were calculated, based on resource …
Authors
Lamy A; Jönsson B; Weintraub WS; Zhao F; Chrolavicius S; Bakhai A; Culler S; Gafni A; Lindgren P; Mahoney E
Journal
European Journal of Preventive Cardiology, Vol. 11, No. 6, pp. 460–465
Publisher
Oxford University Press (OUP)
Publication Date
December 2004
DOI
10.1097/00149831-200412000-00003
ISSN
2047-4873